Renal Denervation on Quality of 24-hr BP Control by Ultrasound In Resistant Hypertension
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 140 participants.
Also called NCT02918305
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 140 participants
- Sponsor
- JIMRO Co., Ltd.
- Registry
-
NCT02918305
-
- Other papers using this trial's data
- Catheter-based ultrasound renal denervation in patients with resistant hypertension: the randomized, controlled REQUIRE trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Japan, South Korea
- Registry status
- Completed
Technical summary
Registry record NCT02918305. Randomized; double masking; primary purpose treatment. Start 2017-01 (actual); primary completion 2020-07 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Renal Denervation on Quality of 24-hr BP Control by Ultrasound In Resistant Hypertension
- Acronym
- REQUIRE
- Condition
- Hypertension
- Condition
- Vascular Diseases
- Intervention (Device)
- PRDS-001 Renal Denervation Ultrasound System
- Intervention (Procedure)
- Sham Procedure
- Lead sponsor
- JIMRO Co., Ltd.
Record details
- Record id
cardio:ct-nct02918305- Content hash
6c4fbd2d47042aff443b5a217adef5b1ca2b40fb7a8b5dbf809eab76f9e24c3f